Redhill Biopharma Ltd (NASDAQ:RDHL)
| 1.26 Delayed Data As of 3:59pm ET |  -0.04 / -3.08%Today’s Change | 0.26 Today|||52-Week Range 11.50 | -77.55% Year-to-Date |
Latest RDHL News | Press Releases
No recent news for Redhill Biopharma Ltd.
Today’s Trading
| Previous close | 1.30 |
| Today’s open | 1.22 |
| Day’s range | 1.08 - 1.38 |
| Volume | 98,590 |
| Average volume (3 months) | 6,963,740 |
| Market cap | $18.4M |
Data as of 3:59pm ET, 12/07/2023
Growth & Valuation
| Earnings growth (last year) | +45.17% |
| Earnings growth (this year) | -2,566.67% |
| Earnings growth (next 5 years) | +113.00% |
| Revenue growth (last year) | -28.27% |
| P/E ratio | NM |
| Price/Sales | 0.14 |
| Price/Book | -- |
Competitors
Data as of 3:57pm ET, 12/07/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $61.6M |
| Annual profit (last year) | -$71.4M |
| Net profit margin | -115.97% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
